(October 26, 2023, 1:57 PM EDT) -- The U.S. Food and Drug Administration has accepted for review AstraZeneca’s Supplemental Biologics License Application (sBLA) to approve its self- or caregiver-administered option for a needle-free nasal spray flu vaccine, the biopharmaceutical company announced....